Business Description
Imagion Biosystems Ltd
NAICS : 621511
SIC : 8099
ISIN : AU000000IBX6
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.03 | |||||
Equity-to-Asset | -1.02 | |||||
Debt-to-Equity | -1.52 | |||||
Debt-to-EBITDA | -0.62 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -30.98 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 70 | |||||
3-Year EBITDA Growth Rate | -12.1 | |||||
3-Year EPS without NRI Growth Rate | -15.3 | |||||
3-Year FCF Growth Rate | -4 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 34.81 | |||||
9-Day RSI | 35.18 | |||||
14-Day RSI | 31.84 | |||||
6-1 Month Momentum % | -83.18 | |||||
12-1 Month Momentum % | -87.67 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.11 | |||||
Quick Ratio | 0.11 | |||||
Cash Ratio | 0.04 | |||||
Days Sales Outstanding | 28.18 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -9.4 | |||||
Shareholder Yield % | -165.48 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -916.29 | |||||
Net Margin % | -794.23 | |||||
FCF Margin % | -517.14 | |||||
ROA % | -193.77 | |||||
ROIC % | -205.49 | |||||
ROC (Joel Greenblatt) % | -281.95 | |||||
ROCE % | -438.42 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 1.37 | |||||
EV-to-EBIT | -0.73 | |||||
EV-to-EBITDA | -0.81 | |||||
EV-to-Revenue | 5.67 | |||||
EV-to-FCF | -1.1 | |||||
Earnings Yield (Greenblatt) % | -136.99 | |||||
FCF Yield % | -352.11 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Imagion Biosystems Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil A$) | 1.645 | ||
EPS (TTM) (A$) | -0.429 | ||
Beta | 0.92 | ||
Volatility % | 65.69 | ||
14-Day RSI | 31.84 | ||
14-Day ATR (A$) | 0.000276 | ||
20-Day SMA (A$) | 0.074 | ||
12-1 Month Momentum % | -87.67 | ||
52-Week Range (A$) | 0.073 - 1.44 | ||
Shares Outstanding (Mil) | 32.65 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Imagion Biosystems Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Imagion Biosystems Ltd Stock Events
Event | Date | Price(A$) | ||
---|---|---|---|---|
No Event Data |
Imagion Biosystems Ltd Frequently Asked Questions
What is Imagion Biosystems Ltd(ASX:IBX)'s stock price today?
When is next earnings date of Imagion Biosystems Ltd(ASX:IBX)?
Does Imagion Biosystems Ltd(ASX:IBX) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |